SCHEMBL8073362

SCHEMBL8073362

CCOC(=O)COc1ccc([C@H]2CCC[C@@H](NC[C@H](O)c3cccc(Cl)c3)C2)cc1

nearest known ligand 0.68

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 11/20 0.68
ADRB1 P08588 5/20 0.50
ADRB2 P07550 2/20 0.47
GLA P06280 1/20 0.47
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7058076 1.00 ADRB3 (0.68) ADRB3ADRB1ADRB2GLAADRA1D
Hydrochloric Acid SCHEMBL7056032 0.99 ADRB3 (0.67) ADRB3ADRB1ADRB2GLAADRA1D
Hydrochloric Acid SCHEMBL8063488 0.99 ADRB3 (0.67) ADRB3ADRB1ADRB2GLAADRA1D
SCHEMBL8076585 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
SCHEMBL7057571 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
SCHEMBL4071036 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
SCHEMBL13799337 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
SCHEMBL4071040 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
SCHEMBL7053502 0.93 ADRB3 (0.67) ADRB3ADRB1ADRB2GLA
Hydrochloric Acid SCHEMBL7053904 0.92 ADRB3 (0.66) ADRB3ADRB1ADRB2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6069176-A PHENYLETHANOLAMINE COMPOUNDS WITH A BETA-3 ADRENERGIC RECEPTOR STIMULATING EFFECT, USE AS A THERAPY FOR URINARY INCONTINENCE MITSUBISHI-TOKYO PHARMACEUTICALS, INC. (JP) 2000-05-30 US disclosed